Form 4 for CLBT Cellebrite DI Ltd.
Accepted 2026-07-07 07:29:43 ET · period of report 2026-07-02 · accession 0001628280-26-047426 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-07-07 07:29 | 2026-07-02 | CLBT | Hogan Thomas E. | CEO, Dir | S - Sale | $15.76 | -103.2K | 590.8K | -15% | -$1.63M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary shares, par value NIS 0.00001 | 2026-07-02 | S | D | 103,188 | $15.76 | 590,777 | D | — | — | (F1) The shares reported as disposed herein were granted on September 19, 2025, in the form of restricted stock units ("RSUs"). The disposition of shares is associated with tax obligations of the reporting person associated with the vesting of the RSUs. (F2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.44 to $15.97, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |